187 related articles for article (PubMed ID: 31944864)
1. Compound heterozygous mutations in the
Liu YD; Lin HJ; Li CY; Sun GF; Hu XB; Ma MY; Sun Y; Feng BZ; Li QB; Kong QX
Int J Neurosci; 2020 Nov; 130(11):1156-1160. PubMed ID: 31944864
[No Abstract] [Full Text] [Related]
2. Genetic assessment of ten Egyptian patients with Sjögren-Larsson syndrome: expanding the clinical spectrum and reporting a novel ALDH3A2 mutation.
Amr K; El-Bassyouni HT; Ismail S; Youness E; El-Daly SM; Ebrahim AY; El-Kamah G
Arch Dermatol Res; 2019 Nov; 311(9):721-730. PubMed ID: 31388754
[TBL] [Abstract][Full Text] [Related]
3. An Indian family with Sjögren-Larsson syndrome caused by a novel ALDH3A2 mutation.
Sakai K; Akiyama M; Yanagi T; Nampoothiri S; Mampilly T; Sunitha V; Shimizu H
Int J Dermatol; 2010 Sep; 49(9):1031-3. PubMed ID: 20883264
[TBL] [Abstract][Full Text] [Related]
4. Sjögren-Larsson syndrome: report of monozygote twins and a case with a novel mutation.
Yiş U; Terrinoni A
Turk J Pediatr; 2012; 54(1):64-6. PubMed ID: 22397046
[TBL] [Abstract][Full Text] [Related]
5. [Sjögren-Larsson syndrome: Pediatric case report].
García-Ortiz L; Gómez-López R; Rivera-Pedroza CI; Santillán-Hernández Y; Chima-Galán MDC; Gutiérrez-Salinas J
Arch Argent Pediatr; 2018 Dec; 116(6):e773-e777. PubMed ID: 30457735
[TBL] [Abstract][Full Text] [Related]
6. Large contiguous gene deletions in Sjögren-Larsson syndrome.
Engelstad H; Carney G; S'aulis D; Rise J; Sanger WG; Rudd MK; Richard G; Carr CW; Abdul-Rahman OA; Rizzo WB
Mol Genet Metab; 2011 Nov; 104(3):356-61. PubMed ID: 21684788
[TBL] [Abstract][Full Text] [Related]
7. Novel and recurrent ALDH3A2 mutations in Italian patients with Sjögren-Larsson syndrome.
Didona B; Codispoti A; Bertini E; Rizzo WB; Carney G; Zambruno G; Dionisi-Vici C; Paradisi M; Pedicelli C; Melino G; Terrinoni A
J Hum Genet; 2007; 52(10):865-870. PubMed ID: 17902024
[TBL] [Abstract][Full Text] [Related]
8. Sjögren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2).
Rizzo WB; Carney G
Hum Mutat; 2005 Jul; 26(1):1-10. PubMed ID: 15931689
[TBL] [Abstract][Full Text] [Related]
9. Genotype and phenotype variability in Sjögren-Larsson syndrome.
Weustenfeld M; Eidelpes R; Schmuth M; Rizzo WB; Zschocke J; Keller MA
Hum Mutat; 2019 Feb; 40(2):177-186. PubMed ID: 30372562
[TBL] [Abstract][Full Text] [Related]
10. Novel mutation in Sjogren-Larsson syndrome is associated with divergent neurologic phenotypes.
Davis K; Holden KR; S'Aulis D; Amador C; Matheus MG; Rizzo WB
J Child Neurol; 2013 Oct; 28(10):1259-65. PubMed ID: 23034980
[TBL] [Abstract][Full Text] [Related]
11. Case of Sjögren-Larsson syndrome with a large deletion in the ALDH3A2 gene confirmed by single nucleotide polymorphism array analysis.
Gaboon NE; Jelani M; Almramhi MM; Mohamoud HS; Al-Aama JY
J Dermatol; 2015 Jul; 42(7):706-9. PubMed ID: 25855245
[TBL] [Abstract][Full Text] [Related]
12. Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
Rizzo WB
Mol Genet Metab; 2007 Jan; 90(1):1-9. PubMed ID: 16996289
[TBL] [Abstract][Full Text] [Related]
13. Sjögren-Larsson syndrome: novel mutations in the ALDH3A2 gene in a French cohort.
Sarret C; Rigal M; Vaurs-Barrière C; Dorboz I; Eymard-Pierre E; Combes P; Giraud G; Wanders RJ; Afenjar A; Francannet C; Boespflug-Tanguy O
J Neurol Sci; 2012 Jan; 312(1-2):123-6. PubMed ID: 21872273
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and mutational spectrum of thirty-five patients with Sjögren-Larsson syndrome: identification of eleven novel ALDH3A2 mutations and founder effects.
Abdel-Hamid MS; Issa MY; Elbendary HM; Abdel-Ghafar SF; Rafaat K; Hosny H; Girgis M; Abdel-Salam GMH; Zaki MS
J Hum Genet; 2019 Sep; 64(9):859-865. PubMed ID: 31273323
[TBL] [Abstract][Full Text] [Related]
15. Sjogren-Larsson Syndrome: A case series of five members from an extended family with a novel mutation.
Abidi KT; Kamal NM; Bakkar A AA; Alotaibi M; Asseri H; Bokari KA
Mol Genet Genomic Med; 2020 Nov; 8(11):e1487. PubMed ID: 32930514
[TBL] [Abstract][Full Text] [Related]
16. Clinical, biochemical, and genetic aspects of Sjögren-Larsson syndrome.
Cho KH; Shim SH; Kim M
Clin Genet; 2018 Apr; 93(4):721-730. PubMed ID: 28543186
[TBL] [Abstract][Full Text] [Related]
17. Neurodegeneration in an adolescent with Sjogren-Larsson syndrome: a decade-long follow-up case report.
Cho KH; Shim SH; Jung Y; Sung SR; Kim M
BMC Med Genet; 2018 Aug; 19(1):152. PubMed ID: 30157790
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive in silico screening and molecular dynamics studies of missense mutations in Sjogren-Larsson syndrome associated with the ALDH3A2 gene.
Udhaya Kumar S; Thirumal Kumar D; Mandal PD; Sankar S; Haldar R; Kamaraj B; Walter CEJ; Siva R; George Priya Doss C; Zayed H
Adv Protein Chem Struct Biol; 2020; 120():349-377. PubMed ID: 32085885
[TBL] [Abstract][Full Text] [Related]
19. Novel ALDH3A2 heterozygous mutations in a Japanese family with Sjögren-Larsson syndrome.
Sakai K; Akiyama M; Watanabe T; Sanayama K; Sugita K; Takahashi M; Suehiro K; Yorifuji K; Shibaki A; Shimizu H
J Invest Dermatol; 2006 Nov; 126(11):2545-7. PubMed ID: 16794583
[No Abstract] [Full Text] [Related]
20. Clinical and molecular characterization and response to acitretin in three families with Sjögren-Larsson syndrome.
Vural S; Vural A; Akçimen F; Bağci IS; Tunca C; Gündoğdu Eken A; Ruzicka T; Başak AN
Int J Dermatol; 2018 Jul; 57(7):843-848. PubMed ID: 29704247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
